Caplight Directory>Investors>Remiges Ventures>Remigesventures


Remiges Ventures

Remiges Ventures

Seattle, Washingtonremigesventures.com

Overview

Remiges Ventures is a cross-border venture capital firm that focuses on therapeutics throughout the United States and Japan. The firm focuses on company creation and investments in early-stage drug discovery and development companies. With its team located in the US and Japan, Remiges Ventures understands the drug discovery and biotech environments in both regions and marries the entrepreneurship and biotech ecosystem in the US with Japan's rich life science innovation.

Year Founded

2014

Portfolio Companies

11

Investments

CompanyDateStageLead
KupandoMar 2026Series A ExtensionLead
GlycomineApr 2025Series C-
Immunis, Inc.Jan 2025Series A ExtensionCo-investor
Restore Vision Inc.Dec 2023Series ALead
Restore Vision Inc.Jun 2023Series ALead
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSeattle, Washington
Year Founded2014

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.